Treatment for bovine Escherichia coli mastitis - an evidence-based approach

Journal of Veterinary Pharmacology and Therapeutics

Volumn 36, Issue 6, 2013, Pages 521-531

  Suojala, L ^a   Kaartinen, L ^b   Pyorala S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATL VET AND FOOD RES INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CEFQUINOME; CEFTIOFUR; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLOXACILLIN; COLISTIN; COTRIMAZINE; DANOFLOXACIN; DEXAMETHASONE; ENROFLOXACIN; ERYTHROMYCIN; FLUNIXIN; FLUNIXIN MEGLUMINE; GENTAMICIN; GLUCOCORTICOID; ISOFLUPREDONE; MARBOFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTETRACYCLINE; PENICILLIN G; PREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM PLUS SULFONAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIOLOGY; BACTERIUM ISOLATION; BOVINE MASTITIS; COLIFORM BACTERIUM; COW; DAIRY CATTLE; DISEASE SEVERITY; DRUG EFFICACY; ESCHERICHIA COLI; EVIDENCE BASED PRACTICE; FLUID THERAPY; GRAM POSITIVE BACTERIUM; HERD; LACTATION; MAMMARY GLAND; MASTITIS; MILK; MILK PRODUCTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VIRULENCE;

ANIMALIA; BOVINAE; ESCHERICHIA COLI; POSIBACTERIA;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; ESCHERICHIA COLI INFECTIONS; FEMALE; MASTITIS, BOVINE;

EID: 84887177472     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/jvp.12057     Document Type: Article

References (118)

1. Almeida, R.A., Dogin, B., Klaessing, S., Schukken, Y.H. & Oliver, S.P. (2011) Intracellular fate of strains of Escherichia coli isolated from dairy cows with acute or chronic mastitis. Veterinary Research Communications, 35, 89-101.
2. Anderson, K.L., Smith, R., Shanks, R.D., Davis, L.E. & Gustafsson, B.K. (1986) Efficacy of flunixin meglumine for the treatment of endotoxin-induced bovine mastitis. American Journal of Veterinary Research, 47, 1366-1372.
3. Andraud, M., Chauvin, C., Sanders, P. & Laurenti, M. (2011) Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains. Antimicrobial Agents and Chemotherapy, 55, 756-761.
4. Banting, A., Banting, S., Heinonen, K. & Mustonen, K. (2008) Efficacy of oral and parenteral ketoprofen in lactating cows with endotoxin-induced acute mastitis. Veterinary Record, 163, 506-509.
5. Barkema, H.W., Schukken, Y.H., Lam, T.J.G.M., Beiboer, M.L., Wilmink, H., Benedictus, G. & Brand, A. (1998) Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. Journal of Dairy Science, 81, 411-419.
6. Barlow, J. (2011) Mastitis therapy and antimicrobial susceptibility: a multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle. Journal of Mammary Gland Biology and Neoplasia, 16, 383-407.
7. Bengtsson, B., Ericsson Unnerstad, H., Ekman, T., Artursson, K., Nilsson-Öst, M. & Persson Waller, K. (2009) Antimicrobial susceptibility of udder pathogens from cases of acute clinical mastitis in dairy cows. Veterinary Microbiology, 136, 142-149.
8. Botrel, M.A., Haenni, M., Morignat, E., Sulpice, P., Madec, J.Y. & Calavas, D. (2010) Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhone-Alpes, France. Foodborne Pathogens and Disease, 7, 479-487.
9. Bradley, A. & Green, M. (2001) Adaptation of Escherichia coli to the bovine mammary gland. Journal of Clinical Microbiology, 39, 1845-1849.
10. Bradley, A.J., Leach, K.A., Breen, J.E., Green, L.E. & Green, M.J. (2007) Survey of the incidence and aetiology of mastitis in dairy farms in England and Wales. Veterinary Record, 160, 253-258.
11. Burvenich, C., Van Merris, V., Mehrzad, J., Diez-Fraile, A. & Duchateau, L. (2003) Severity of E. coli mastitis is mainly determined by cow factors. Veterinary Research, 34, 521-564.
12. Burvenich, C., Bannerman, D.D., Lippolis, J.D., Peelman, L., Nonnecke, B.J., Kehrli, M.E. & Paape, M.J. (2007) Cumulative physiological events influence the inflammatory response of the bovine udder to Escherichia coli infections during the transition period. Journal of Dairy Science, 90(Suppl. 1), 39-54.
13. Carroll, E., Schalm, O. & Lasmanis, J. (1965) The use of a synthetic corticoid on experimental coliform (Aerobacter aerogenes) mastitis in cattle: the effects of intramammary and intramuscular administration on the inflammatory response. American Journal of Veterinary Research, 26, 858-864.
14. Cebra, C., Garry, F. & Dinsmore, R. (1996) Naturally occurring acute coliform mastitis in Holstein cattle. Journal of Veterinary Internal Medicine, 10, 252-257.
15. Collignon, P., Powers, J., Chiller, T., Aidara-Kane, A. & Aarestrup, F. (2009) World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clinical Infectious Diseases, 49, 132-141.
16. Constable, P., Pyörälä, S. & Smith, G. (2008) Guidelines for antimicrobial use in cattle. In Antimicrobial Use in Animals. Eds Guardabassi, L., Jensen, L.B. & Kruse, H., pp. 143-160. Blackwell Publishing Ltd, Oxford, UK.
17. Doern, G.V. & Brecher, S.M. (2011) The clinical predictive value (or Lack Thereof) of the results of in vitro antimicrobial susceptibility tests. Journal of Clinical Microbiology, 49, S11-S14.
18. Dogan, B., Klaessig, S., Rishniw, M., Almeida, R.A., Oliver, S.P., Simpson, K. & Schukken, Y.H. (2006) Adherent and invasive Escherichia coli are associated with persistent bovine mastitis. Veterinary Microbiology, 116, 270-282.
19. Döpfer, D., Barkema, H.W., Lam, T.J.G.M., Schukken, Y. & Gaastra, W. (1999) Recurrent clinical mastitis caused by Escherichia coli in dairy cows. Journal of Dairy Science, 82, 80-85.
20. Dosogne, H., Meyer, E., Sturk, A., Van Loon, J., Massart-Leion, A. & Burvenich, C. (2002) Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflammation Research, 51, 201-205.
21. Dube, C., Goodell, G.M. & Dinsmore, R.P. (2001) Comparison of two clinical mastitis management protocols for predicting case outcome and cow survivability. Proceedings of 2nd Annual International Symposium on Mastitis and Milk Quality, pp. 116-120. National Mastitis Council, Vancouver, BC, Madison WI.
22. Dyer, J.G., Sriranganathan, N., Nickerson, S.C. & Elfinger, F. (2007) Curli production and genetic relationships among Escherichia coli from cases of bovine mastitis. Journal of Dairy Science, 90, 193-201.
23. EFSA (2011) Scientific opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA Journal, 9, 2322.
24. Ehinger, A.M., Schmidt, M. & Kietzmann, M. (2006) Tissue distribution of cefquinome after intramammary and ''systemic'' administration in the isolated perfused bovine udder. Veterinary Journal, 172, 147-153.
25. EMA European Medicine Agency (2003) Guideline for demonstration of efficacy for veterinary medicinal products containing antimicrobial substances. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004492.pdf.
26. EMA European Medicine Agency (2010) Opinion following an Article 35 referral for all veterinary medicinal products containing quinolones including fluoroquinolones intended for use in food-producing species. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/referrals/Quinolones_containing_medicinal_products/vet_referral_000039.jsp&mid=WC0b01ac05805c5170.
27. EMEA European Medicine Agency (2006) Reflection paper on use of fluoroquinolones in food-producing animals in the European Union: development of resistance and impact on human and animal health. www.ema.europa.eu/pdfs/vet/srwp/18465105en.pdf-2008-11-25.
28. Endimiani, A., Bertschy, I. & Perreten, V. (2012) Escherichia coli producing CMY-2 β-lactamase in bovine mastitis milk. Journal of Food Protection, 75, 137-138.
29. Ericsson Unnerstad, H., Lindberg, A., Persson Waller, K., Ekman, T., Artursson, K., Nilsson-Ost, M. & Bengtsson, B. (2009) Microbial aetiology of acute clinical mastitis and agent-specific risk factors. Veterinary Microbiology, 137, 90-97.
30. Erskine, R.J., Tyler, J.W., Riddell, M.G. Jr & Wilson, R.C. (1991) Theory, use and realities of efficacy and food safety of antimicrobial treatment of acute coliform mastitis. Journal of the American Veterinary Medical Association, 198, 980-984.
31. Erskine, R.J., Wilson, R.C., Riddell, M.G. Jr, Tyler, J.W., Spears, H.J. & Davis, B.S. (1992) Intramammary administration of gentamicin as treatment for experimentally induced Escherichia coli mastitis in cows. American Journal of Veterinary Research, 53, 375-381.
32. Erskine, R.J., Wilson, R.C., Tyler, J.W., McClure, K.A., Nelson, R.S. & Spears, H.J. (1995) Ceftiofur distributions in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis. American Journal of Veterinary Research, 56, 481-485.
33. Erskine, R., Bartlett, P., VanLente, J. & Phipps, R. (2002) Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. Journal of Dairy Science, 85, 2571-2575.
34. Erskine, R.J., Wagner, S. & DeGraves, F.J. (2003) Mastitis therapy and pharmacology. Veterinary Clinics of North America: Food Animal Practice, 19, 109-138.
35. Ewers, C., Bethe, A., Semmler, T., Guenther, S. & Wieler, L.H. (2012) Extended-spectrum beta-lactamase- (ESBL-) and AmpC- producing Escherichia coli from livestock and companion animals and their putative impact on public health: a global perspective. Clinical Microbiology and Infection, 18, 646-655.
36. Fang, W. & Pyörälä, S. (1996) Mastitis-causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk. Journal of Dairy Science, 79, 76-82.
37. FARM 2007-2008(2010) French antimicrobial resistance monitoring program for bacteria of animal origin. ANSES. http://www.anses.fr/Documents/SANT-Ra-FARM2008.pdf
38. FDA (2012) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm285704.htm.
39. FINRES-Vet 2005-2006 (2007) Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents. Evira publications 22/2007. http://www.evira.fi/uploads/WebShopFiles/1198141211941.pdf.
40. Golodetz, C. & White, M. (1983) Prognosis for cows with severe clinical coliform mastitis. Veterinary Record, 112, 402-403.
41. Gonen, E., Vallon-Eberhard, A., Elazar, S., Harmelin, A., Brenner, O., Rosenshine, I., Jung, S. & Shpigel, N. (2007) Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cellular Microbiology, 9, 2826-2838.
42. Grandemange, E., Woehrle, F. & Boisrame, B. (2004) Field evaluation of the efficacy of marbofloxacin in the treatment of acute mastitis due to Gram-negative bacteria in the dairy cow. Proceedings of the XXII World Buiatrics Congress, pp. 183, Canada.
43. Green, M.J., Green, L.E. & Cripps, P.J. (1997) Comparison of fluid and flunixin meglumine therapy in combination and individually in the treatment of toxic mastitis. Veterinary Record, 140, 149-152.
44. Greko, C., Badiola, J.I., Catry, B., van Dujkeren, E., Moreno, M.A., Matias Ferreira Pomba, M.C., Pyörälä, S., Ru-zauskas, M., Sanders, P., Threlfall, E.J., Ungemach, F., Törneke, K. & Torren-Edo, J. (2009) Reflection paper on the use of third and fourth generation cephalosporins in food producing animals in the European Union: development of resistance and impact on human and animal health. Journal of Veterinary Pharmacology and Therapeutics, 32, 515-533.
45. Guterbock, W., Van Eenennaam, A., Anderson, R., Gardner, I., Cullor, J. & Holmberg, C. (1993) Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens. Journal of Dairy Science, 76, 3437-3444.
46. Hill, A. (1984) Progressive pathology of severe Escherichia coli mastitis in dairy cows. Research in Veterinary Science, 37, 179-187.
47. Hoeben, D., Montfardini, E., Burvenich, C. & Hamann, J. (2000) Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: effect on clinical symptoms and chemiluminescence of circulating neutrophils. Journal of Dairy Research, 67, 485-502.
48. Hogan, J. & Smith, L. (2003) Coliform mastitis. Veterinary Research, 34, 507-519.
49. Huxley, J. (2004) Clinical forum - E. coli mastitis. Cattle Practice, 9, 1-7.
50. Jones, G. & Ward, G. (1990) Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows. Journal of the American Veterinary Medical Association, 197, 731-735.
51. Kaartinen, L., Salonen, M., Älli, L. & Pyörälä, S. (1995) Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. Journal of Veterinary Pharmacology and Therapeutics, 18, 357-362.
52. Kaartinen, L., Löhönen, K. & Wiese, B. (1999) Pharmacokinetics of sulphadiazine-trimethoprim in lactating dairy cows. Acta Veterinaria Scandinavica, 40, 271-278.
53. Katholm, J. (2003) Treatment of coliform mastitis in bovine practice. Can antibiotics be avoided? Acta Veterinaria Scandinavica. Supplementum., 98, 183-184.
54. Katholm, J. & Andersen, H. (1992) Acute coliform mastitis in dairy cows: endotoxin and biochemical changes in plasma and colony-forming units in milk. Veterinary Record, 131, 513-514.
55. Kietzmann, M., Braun, M., Schneider, M. & Pankow, R. (2008) Tissue distribution of marbofloxacin after 'systemic' administration into the isolated perfused bovine udder. Veterinary Journal, 178, 115-118.
56. Kornalijnslijper, J.E., Daemen, A.J., Van Werwen, T., Niewold, T.A., Rutten, V.P. & Noordhuizen-Stassen, E.N. (2004) Bacterial growth during the early phase of infection determines the severity of experimental Escherichia coli mastitis in dairy cows. Veterinary Microbiology, 101, 177-186.
57. Krömker, V., Zinke, C., Paduch, J.-H., Klocke, D., Reimann, A. & Eller, G. (2010) Evaluation of increased milking frequency as an additional treatment for cows with clinical mastitis. Journal of Dairy Research, 77, 90-94.
58. Kuang, Y., Jia, H., Miyanaga, K. & Tanji, Y. (2009) Effect of milk on antibacterial activity of tetracycline against Escherichia coli and Staphylococcus aureus isolated from bovine mastitis. Applied Microbiology and Biotechnology, 84, 135-142.
59. Kutila, T., Suojala, L., Lehtolainen, T., Saloniemi, H., Kaartinen, L., Tähti, M., Seppälä, K. & Pyörälä, S. (2004) The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis. Journal of Veterinary Pharmacology and Therapeutics, 27, 197-202.
60. Lago, A., Godden, S.M., Bey, R., Ruegg, P.L. & Leslie, K. (2011) The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes. Journal of Dairy Science, 94, 4441-4456.
61. Lam, T.J.G.M., Lipman, L.J.A., Schukken, Y.H., Gaastra, W. & Brand, A. (1996) Epidemiological characteristics of bovine clinical mastitis caused by Escherichia coli and Staphylococcus aureus studied by DNA fingerprinting. American Journal of Veterinary Research, 57, 38-42.
62. Lehtolainen, T., Pohjanvirta, T., Pyörälä, S. & Pelkonen, S. (2003) Association between virulence factors and clinical course of Escherichia coli mastitis. Acta Veterinaria Scandinavica, 44, 203-205.
63. Leininger, D., Roberson, J., Elfinger, F., Ward, D. & Akers, M. (2003) Evaluation of frequent milkout for treatment of cows with experimentally induced Escherichia coli mastitis. Journal of the American Veterinary Medical Association, 222, 63-66.
64. Lepper, P., Held, T., Schneider, E., Bölke, E., Gerlach, H. & Trautmann, M. (2002) Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Medicine, 28, 824-833.
65. Leslie, K.E., Kielland, C. & Millman, S. (2010) Is mastitis painful and is therapy for pain beneficial? Proceedings of National Mastitis Council, pp. 114-130, Albuquerque, NM, USA.
66. Locatelli, C., Caronte, I., Scaccabarozzi, L., Migliavacca, R., Pagani, L. & Moroni, P. (2009) Extended-spectrum β-lactamase production in E. coli strains isolated from clinical bovine mastitis. Veterinary Research Communications, 33 (Suppl. 1), 141-144.
67. Lohuis, J.A., Van Leeuwen, W. & Verheijden, J.H.M. (1988) Effect of dexamethasone on experimental Escherichia coli mastitis in the cow. Journal of Dairy Science, 71, 2782-2789.
68. Lohuis, J.A., Van Leeuwen, W., Verheijden, J.H., Brand, A. & Van Miert, A.S. (1989) Effect of steroidal anti-inflammatory drugs on Escherichia coli endotoxin-induced mastitis in the cow. Journal of Dairy Science, 72, 241-249.
69. MARAN (2009) Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2008. http://www.wageningenur.nl/nl/Expertises-Dienstverlening/Onderzoeksinstituten/central-veterinary-institute/Publicaties-CVI/MARAN-Rapporten.htm.
70. Marshall, B.M. & Levy, S.B. (2011) Food animals and antimicrobials: impacts on human health. Clinical Microbiology Reviews, 24, 718.
71. Mestorino, N., Marchetti, M.L., Turic, E., Pesoa, J. & Errecalde, J. (2009) Concentrations of danofloxacin 18% solution in plasma, milk and tissues after subcutaneous injection in dairy cows. Analytica Chimica Acta, 637, 33-39.
72. Morin, D., Shanks, R. & McCoy, G. (1998) Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis. Journal of the American Veterinary Medical Association, 213, 676-684.
73. NMSM (2009) Nordiska riktlinjer för mastitbehandlung (Nordic guidelines for mastitis treatment). Nordic Dairy Association′s Committee for Milk Quality, Sweden. http://www.sva.se/upload/Redesign2011/Pdf/antibiotika/Nordiska_riktlinjer_for_mastitbehandling_lagupplost.pdf.
74. Olde Riekerink, R.G., Barkema, H.W., Kelton, D.F. & Scholl, D.T. (2008) Incidence rate of clinical mastitis on Canadian dairy farms. Journal of Dairy Science, 91, 1366.
75. Owens, W., Xiang, Z., Ray, C. & Nickerson, S. (1990) Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy. Journal of Dairy Science, 73, 3449-3456.
76. Pasquali, F. & Manfreda, G. (2007) Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Veterinary Microbiology, 119, 304-310.
77. Persson, Y., Katholm, J., Landin, H. & Mörk, M. (2013) Efficacy of enrofloxacin for treatment of acute clinical mastitis caused by Escherichia coli. The 29th NKVet Symposium: Mastitis - new knowledge on diagnostics and control on modern dairy farm. Reykjavik, Iceland.
78. Pinzón-Sánchez, C., Cabrera, V.E. & Ruegg, P.L. (2011) Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation. Journal of Dairy Science, 94, 1873-1892.
79. Poutrel, B. & Dellac, B. (2004) A systemic treatment of acute coliform mastitis with enrofloxacin improves the general health status of the daisy cow. Poster presentation in World Buiatrics Congress, Quebec, Canada.
80. Poutrel, B., Stegemann, M., Roy, O., Pothier, F., Tilt, N. & Payne-Johnson, M. (2008) Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. Journal of Dairy Research, 75, 310-318.
81. Pyörälä, S. & Pyörälä, E. (1997) Accuracy of methods using somatic cell count and milk N-acetyl-β-d-glucosaminidase activity in milk to assess the bacteriological cure of bovine clinical mastitis. Journal of Dairy Science, 80, 2820-2825.
82. Pyörälä, S. & Pyörälä, E. (1998) Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995). Journal of the American Veterinary Medical Association, 212, 407-412.
83. Pyörälä, S. & Syväjärvi, J. (1987) Bovine acute mastitis. Part II. Effect of mastitis pathogen, initial inflammatory reaction and therapy on the outcome of the disease. Journal of Veterinary Medicine B Series B, 34, 629-639.
84. Pyörälä, S., Kaartinen, L., Käck, H. & Rainio, V. (1994) Efficacy of two therapy regimens for treatment of experimentally induced Escherichia coli mastitis in cows. Journal of Dairy Science, 77, 453-461.
85. Radostits, O.M., Gay, C.C., Hinchcliff, K.W. & Constable, P.D. (2007) Veterinary Medicine, 10th edn. Saunders Elsevier, Philadelphia, PA, USA.
86. Rantala, M., Kaartinen, L., Välimäki, E., Stryrman, M., Hiekkaranta, M., Niemi, A., Saari, L. & Pyörälä, S. (2002) Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. Journal of Veterinary Pharmacology and Therapeutics, 25, 251-258.
87. Roberson, J. (2003) Treatment of E. coli & Klebsiella: mild to moderate cases. Proceedings of North American Veterinary Conference 2003, pp. 94-96, Large Animal, Eastern States Veterinary Association, Orlando, FL, Gainesville, FL.
88. Roberson, J.R. (2012) Treatment of clinical mastitis. Veterinary Clinics of Food Animals, 28, 271-288.
89. Ruegg, P. (2010) The application of evidence based medicine to mastitis therapy. Eds Wittwer, F., Chihuailaf, R., Contreras, H., Gallo, C., Kruze, J., Lanuza, F., Letelier, C., Monti, G. & Noro, M. Updates on Ruminant Production and Medicine. XXVI World Buiatrics Congress, Santiago, Chile.
90. Schneider, M., Valle, M., Woehrle, F. & Boisrame, B. (2004) Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. Journal of Dairy Science, 87, 202-211.
91. Schukken, Y. & DeLuyker, H. (1995) Design of field trials for the evaluation of antibacterial products for therapy of bovine clinical mastitis. Journal of Veterinary Pharmacology and Therapeutics, 18, 274-283.
92. Schukken, Y.H., Bennett, G.J., Zurakowski, M.J., Sharkey, H.L., Rauch, B.J., Thomas, M.J., Ceglowski, B., Saltman, R.L., Belomestnykh, N. & Zadoks, R.N. (2011) Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis. Journal of Dairy Science, 94, 6203-6215.
93. Schwarz, S., Silley, P., Simjee, S., Woodford, N., Van Duijkeren, E., Johnson, A. & Gaastra, W. (2010) Assessing the antimicrobial susceptibility of bacteria obtained from animals. Veterinary Microbiology, 141, 1-4.
94. Sears, P.M., Ackerman, C.E. & Crandall, K.M. (2004) Treatment of persistent Escherichia coli mastitis on a large dairy. Proceedings of 37th Annual Convention American Association of Bovine Practitioners, pp. 188-189, Frontier Printers, Fort Worth, TX, Stillwater, OK.
95. Sérieys, F., Raguet, Y., Goby, L., Schmidt, H. & Friton, G. (2005) Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. Journal of Dairy Science, 88, 93-99.
96. Shem-Tov, M., Rav-Hon, O., Ziv, G., Lavi, E., Glickman, A. & Saran, A. (1998) Pharmacokinetics and penetration of danofloxacin from the blood in to the milk of cows. Journal of Veterinary Pharmacology and Therapeutics, 21, 209-213.
97. Shpigel, N., Chen, R., Winkler, M., Saran, A., Ziv, G. & Longo, F. (1994) The anti-inflammatory ketoprofen in the treatment of field cases of bovine mastitis. Research in Veterinary Science, 56, 62-68.
98. Shpigel, N., Levin, D., Winkler, M., Saran, A., Ziv, G. & Böttner, A. (1997) Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. Journal of Dairy Science, 80, 318-323.
99. Shpigel, N.Y., Elazar, S. & Rosenshine, I. (2008) Mammary pathogenic Escherichia coli. Current Opinion in Microbiology, 11, 60-65.
100. Shuster, D.E., Lee, E.K. & Kehrli, M.E. (1996) Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation. American Journal of Veterinary Research, 57, 1569-1575.
101. Smith, G.W. (2005) Supportive therapy of the toxic cow. Veterinary Clinics of North America: Food Animal Practice, 21, 595-614.
102. Stockler, R., Morin, D., Lantz, R., Hurley, W. & Constable, P. (2009) Effect of milk fraction on concentrations of cephapirin and desacetylcephapirin in bovine milk after intramammary infusion of cephapirin sodium. Journal of Veterinary Pharmacology and Therapeutics, 32, 345-352.
103. Suojala, L., Simojoki, H., Mustonen, K., Kaartinen, L. & Pyörälä, S. (2010) Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. Journal of Dairy Science, 93, 1960-1969.
104. Suojala, L., Pohjanvirta, T., Simojoki, H., Myllyniemi, A.-L., Pitkälä, A., Pelkonen, S. & Pyörälä, S. (2011) Phylogeny, virulence factors and antimicrobial susceptibility of Escherichia coli isolated in clinical bovine mastitis. Veterinary Microbiology, 147, 383-388.
105. Tyler, J.W., DeGraves, F.J., Erskine, R.J., Riddell, M.G., Lin, H.C. & Kirk, J.H. (1994) Milk production in cows with endotoxin-induced mastitis treated with isotonic or hypertonic sodium chloride solution. Journal of the American Veterinary Medical Association, 204, 1949-1952.
106. Vandeputte-Van Messom, G., Burvenich, C., Roets, E., Massart-Leën, A.-M., Heyneman, R., Kremer, W. & Brand, A. (1993) Classification of newly calved cows into moderate and severe responders to experimentally induced Escherichia coli mastitis. Journal of Dairy Research, 60, 19-29.
107. Vangroenweghe, F., Duchateau, L., Boutet, P., Lekeux, P., Rainard, P., Paape, M.J. & Burvenich, C. (2005) Effect of carprofen treatment following experimentally induced Escherichia coli mastitis in primiparous cows. Journal of Dairy Science, 88, 2361-2376.
108. Wagner, S.A. & Apley, M.D. (2003) Pharmacodynamics of isoflupredone acetate in an endotoxin-induced mastitis model. Journal of Dairy Science, 86, 792-798.
109. Wagner, S.A. & Apley, M.D. (2004) Effects of two anti-inflammatory drugs on physiologic variables and milk production in cows with endotoxin-induced mastitis. American Journal of Veterinary Research, 65, 64-68.
110. Wenz, J., Barrington, G., Garry, F., McSweeney, K., Dinsmore, R., Goodell, G. & Callan, R. (2001) Bacteremia associated with naturally occurring acute coliform mastitis in dairy cows. Journal of the American Veterinary Medical Association, 219, 976-981.
111. Wenz, J., Garry, F., Lombard, J., Elia, R., Prentice, D. & Dinsmore, R. (2005) Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle. Journal of Dairy Science, 88, 3496-3499.
112. Wenz, J.R., Barrington, G.M., Garry, F.B., Ellis, R.P. & Magnuson, R.J. (2006a) Escherichia coli isolates' serotypes, genotypes, and virulence genes and clinical coliform mastitis severity. Journal of Dairy Science, 89, 3408-3412.
113. Wenz, J.R., Garry, F.B. & Barrington, G.M. (2006b) Comparison of disease severity scoring systems for dairy cattle with acute coliform mastitis. Journal of the American Veterinary Medical Association, 229, 259-262.
114. Wilson, C. & Gilbert, G. (1986) Pharmacokinetics of cefoperazone in the cow by the intramammary route and its effect on mastitis pathogens in vitro. Veterinary Record, 118, 607-609.
115. Yeiser, E.E., Leslie, K.E., McGilliard, M.L. & Petersson-Wolfe, C.S. (2012) The effects of experimentally induced Escherichia coli mastitis and flunixin meglumine administration on activity measures, feed intake, and milk parameters. Journal of Dairy Science, 95, 4939-4949.
116. Ziv, G. (1980) Practical pharmacokinetic aspects of mastitis therapy - 2. Practical and therapeutic applications. Agricultre Practice, March, 469-476.
117. Ziv, G. & Schultze, W.D. (1983) Influence of intramammary infusion of polymyxin B on the clinicopathologic course of endotoxin-induced mastitis. American Journal of Veterinary Research, 44, 1446-1450.
118. Zonca, A., Gallo, M., Locatelli, C., Carli, S., Moroni, P., Villa, R. & Cagnardi, P. (2011) Cefquinome sulphate behaviour after intramammary administration in healthy and infected cows. Journal of Dairy Science, 94, 3455-3461.